Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  Suppression of T cell immunity and antibody production during virus infection and sepsis


   Cardiff School of Medicine

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Dr J McLaren, Prof Matthias Eberl, Dr G Jones  No more applications being accepted  Competition Funded PhD Project (UK Students Only)

About the Project

Summary
The generation of protective antibodies against virus infections is critically dependent on help from CD4+ T follicular helper (TFH) cells which are elicited in response to viruses, such as influenza and SARS CoV-2. However, these cells notably decline when immune responses are over-exaggerated (sepsis). The PhD student will combine core immunological, virological and innovative gene profiling techniques to examine how and why CD4+ TFH cells decline during sepsis.

Description Significance
Antibody production is a major correlate of protective immunity elicited by vaccination or infection. The generation of antibodies in germinal centres of secondary lymphoid organs is critically dependent on “help” from CD4+ T follicular helper (TFH) cells which are elicited in response to viruses, such as influenza and SARS CoV-2. However, immune responses to infection can become over-exaggerated, such as in sepsis, which induces hyper-inflammation and an accompanying cytokine “storm” that is life-threatening to patients. Sepsis is the primary cause of death in hospitalized patients in the UK (52,000 deaths/year), yielding a substantial economic (>£7billion/year) burden. It is a serious complication of viral (e.g. influenza) and bacterial (e.g. Staphylococcus aureus) infections and can occur in patients with COVID-19. Sepsis evokes defined suppression in cellular (T cell) and humoral (antibodies) adaptive immunity, which is a driving force behind morbidity and mortality. However, our knowledge on the fundamental mechanics driving the suppression of cellular and humoral adaptive immunity in sepsis is poor.

Originality
There is evidence that CD4+ TFH cells decline during sepsis in humans and mice but the reasons why are unknown. A biological trigger for this might originate from the infectious source since Gram-positive bacteria, such as Staphylococcus aureus (a leading cause of sepsis), can secrete potent toxins (superantigens) that target T cells to induce cellular dysfunction and excessive cytokine production. Recent evidence in children with recurrent tonsillitis suggests that bacterial superantigens can target CD4+ TFH cells, skewing them into pathogenic, B cell killing effectors. Superantigens harness the actions of T cell-modulating cytokines, such as IL-12, and actively up-regulate the expression of co-inhibitory receptors (e.g. LAG-3) on T cells. IL-27, a member of the IL-12 cytokine family, influences CD4+ TFH cell development and function, and can trigger cellular dysfunction in T cells by driving the programming of coinhibitory receptors. Sepsis patients display elevated levels of IL-27, which negatively correlate with survival, suggesting that IL-27 may become pathogenic when over-expressed. However, a causal link between high levels of IL-27 in patients and CD4+ TFH cell suppression in sepsis has not been defined nor whether superantigens mechanistically exploit IL-27.

Objective
The student will combine immunological, virological and innovative gene profiling techniques to examine how and why CD4+ TFH cells decline during sepsis and will determine whether bacterial superantigens use IL-27 to drive dysfunction in virus-specific CD4+ TFH cells. The specific aims are:
• Aim 1: To examine transcriptomic signatures of CD4+ TFH cell immunosuppression in human patients with sepsis
• Aim 2: To study the potential for IL-27 to direct mechanisms of immunosuppression in human and mouse CD4+ TFH cells
• Aim 3: To profile superantigen-directed immunosuppression in CD4+ TFH cells

Research Training
The student will receive expert training in core immunological techniques (cell culture, flow cytometry, ELISA), virology, animal husbandry, gene profiling strategies (RNA sequencing) and bioinformatics (Ingeniuty Pathway Analysis). Added-value: The student will work across disciplinary boundaries, by combining biological and mathematical approaches, and will benefit from established local and international collaborations in Cardiff, Bristol and Australia.

Knowledge transfer and impact
The student will publicise their research through peerreviewed publications and presentations at institutional seminars, research days and external scientific meetings or conferences. Outreach to lay audiences will be performed using social media, institute websites and engagement opportunities arranged under guidance from Prof. Eberl (Academic Lead for Public Involvement and Engagement).

Funding Notes

A GW4 BioMed MRC DTP studentship includes full tuition fees at the UK/Home rate, a stipend at the minimum UKRI rate, a Research & Training Support Grant (RTSG) valued between £2-5k per year and £300 annual travel and conference grant based on a 3.5-year, full-time studentship.
These funding arrangements will be adjusted pro-rata for part-time studentships. Throughout the duration of the studentship, there will be opportunities to apply to the Flexible Funding Supplement for additional support to engage in high-cost training opportunities.

References

ELIGIBILITY

International and EU students are eligible to apply for these studentships but should note that they may have to pay the difference between the home UKRI fee ( https://www.ukri.org/skills/funding-for-research-training/ ) and the institutional International student fee ( https://www.cardiff.ac.uk/__data/assets/pdf_file/0008/1735154/Fees-Template-PGR-International-2020-21-Version-1-04.12.2019.pdf ). We will update applicants when further information becomes available.

ENTRY REQUIREMENTS

Applicants should possess a minimum of an upper second class Honours degree, master's degree, or equivalent in a relevant subject. 
Applicants whose first language is not English are normally expected to meet the minimum University requirements (e.g. 6.5 IELTS) 

In addition to those with traditional biomedical or psychology backgrounds, the DTP welcomes students from non-medical backgrounds, especially in areas of computing, mathematics and the physical sciences. Further training can be provided to assist with discipline conversion for students from non-medical backgrounds.

HOW TO APPLY

Stage 1: Applying to the DTP for an Offer of Funding
Please follow the instructions at the following link to apply to the DTP.
https://www.gw4biomed.ac.uk/doctoral-students/

Stage 2: Applying to the lead institution for an Offer of Study

This studentship has a start date of October 2021. In order to be considered you must submit a formal application via Cardiff University’s online application service. (To access the application system, click the 'Visit Institution' button on this advert) 
There is a box at the top right of the page labelled ‘Apply’, please ensure you select the correct ‘Qualification’ (Doctor of Philosophy), the correct ‘Mode of Study’ (Full Time) and the correct ‘Start Date’ (October 2021). This will take you to the application portal. 
In order to be considered candidates must submit the following information: 

• Supporting statement 
• CV 
• Qualification certificates 
• Proof of English language (if applicable)
• In the research proposal section of the application, please specify the project title and supervisors of the project and copy the project description in the text box provided. In the funding section, select “I will be applying for a scholarship/grant” and specify advertised funding from GW4 BioMed MRC DTP. If you are applying for more than one Cardiff University project, please note this in the research proposal section as the form only allows you to enter one title.

Where will I study?